WEBHPTN research studies are developed by protocol teams that include CTU investigators and recognized experts in HIV prevention. As study protocols are developed, they undergo a …
HPTN 084
HPTN 084 Open Label Extension (OLE) HPTN 084 OLE FAQ V1.0 - 30 August …
HVTN 805/Hptn 093
Procedures for accessing external funding sources for PrEP and ART provision are …
HPTN 083
HPTN 083 is the first study to compare the efficacy of CAB LA to daily oral …
WEBMar 20, 2024 · About Us. The HPTN strives to evaluate and implement cutting-edge biomedical, behavioral, and structural interventions to reduce the transmission of HIV. Who We Are. The HPTN has more than 50 …
WEBAug 11, 2021 · In the HPTN 083 trial, we compared the safety and efficacy of CAB-LA with that of TDF–FTC for the prevention of HIV infection in MSM and transgender women …
- Author: Raphael J Landovitz, Deborah Donnell, Meredith E Clement, Brett Hanscom, Leslie Cottle, Lara Coelho,...
- Publish Year: 2021
The HIV Prevention Trials Network (HPTN) is a worldwide collaborative clinical trials network that brings together investigators, ethicists, community and other partners to develop and test the safety and efficacy of interventions designed to prevent the acquisition and transmission of HIV. HPTN studies evaluate new HIV prevention interventions and strategies in populations and geographical regio…
Wikipedia · Text under CC-BY-SA license- Type: Nonprofit organization
- Key people: Myron Cohen, MD, HPTN Principal Investigator, Wafaa El-Sadr MD, MPH, MPA, HPTN Principal Investigator
- Industry: HIV Prevention Research
WEBHPTN 083 and an ongoing companion study called HPTN 084, which is evaluating long-acting injectable cabotegravir for HIV prevention in cisgender women in sub-Saharan …
WEBSep 1, 2016 · An interim analysis of data from the HIV Prevention Trials Network (HPTN) 052 trial showed that antiretroviral therapy (ART) prevented more than 96% of genetically linked infections caused by...
WEBApr 1, 2022 · The HPTN 084 trial showed that cabotegravir administered intramuscularly every 8 weeks was effective in preventing HIV infection in women at substantial risk for acquiring HIV in sub-Saharan Africa. …
ViiV Healthcare研发的卡博特韦每两月给药一次长效注射剂疗效优 …
WEB全球新闻. 伦敦，2020年5月18日—— ViiV Healthcare是一家专注于艾滋病治疗的跨国公司，由GSK控股，辉瑞公司和盐野义制药持股。 该公司今天宣布了艾滋病预防试验 …
WEBNov 17, 2017 · Read more about this network: HIV Prevention Trials Network (HPTN) Content last reviewed on November 17, 2017. The HIV Prevention Trials Network …
WEBNote: These sites are HPTN-specific and the map does not include all sites conducting HPTN studies. Clinical Research Sites. UVRI-IAVI HIV Vaccine Program LTD.
Related searches for hptn.yqiqt.cn
- Some results have been hidden because they may be inaccessible to you.Show inaccessible results
Skip to content